Sitosterolemia Extension Study (0653-004)(COMPLETED)
NCT00092820
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Lipid Metabolism, Inborn Errors
Heart Disease
Interventions
DRUG:
MK0653, ezetimibe
DRUG:
Comparator: placebo
Sponsor
Organon and Co